Ionis Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IONS and other ETFs, options, and stocks.About IONS
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T.
IONS Key Statistics
Stock Snapshot
Ionis Pharmaceuticals(IONS) stock is priced at $75.45, giving the company a market capitalization of 12.48B. It carries a P/E multiple of -35.89.
As of 2026-05-05, Ionis Pharmaceuticals(IONS) stock has fluctuated between $74.47 and $76.00. The current price stands at $75.45, placing the stock +1.3% above today's low and -0.7% off the high.
Ionis Pharmaceuticals(IONS) shares are trading with a volume of 1.67M, against a daily average of 2.14M.
During the past year, Ionis Pharmaceuticals(IONS) stock moved between $31.66 at its lowest and $86.74 at its peak.
During the past year, Ionis Pharmaceuticals(IONS) stock moved between $31.66 at its lowest and $86.74 at its peak.
IONS News
Ionis Pharmaceuticals (IONS) has been in focus after a busy stretch that included US FDA Priority Review and Breakthrough Therapy designations for partner drug...
Stifel raised the firm’s price target on Ionis Pharmaceuticals (IONS) to $86 from $83 and keeps a Hold rating on the shares. Unlock hedge fund-level data and p...
Ionis Pharmaceuticals Inc. ((IONS)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level d...
Analyst ratings
88%
of 24 ratingsMore IONS News
In a report released today, Joseph Stringer from Needham maintained a Buy rating on Ionis Pharmaceuticals, with a price target of $105.00. Unlock hedge fund-le...
Image source: The Motley Fool. Wednesday, April 29, 2026 at 11:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer — Brett P. Monia Chief Financial Officer —...
Reports Q1 revenue $246M, consensus $196.01M. “Ionis’ strong performance in the first quarter of 2026 underscores the strength of our commercial and R&D engines...
GSK (GSK) announced on Tuesday that the U.S. Food and Drug Administration (FDA) granted priority review for its marketing application for bepirovirsen, a hepati...
Ionis Pharmaceuticals (IONS) partner GSK (GSK) announced the FDA has accepted for priority review the new drug application, or NDA, for bepirovirsen, an investi...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.